Patterns of bone mineral density testing: current guidelines, testing rates, and interventions.

OBJECTIVES To identify potential obstacles to bone mineral density (BMD) testing, we performed a structured review of current osteoporosis screening guidelines, studies of BMD testing patterns, and interventions to increase BMD testing. DESIGN We searched medline and HealthSTAR from 1992 through 2002 using appropriate search terms. Two authors examined all retrieved articles, and relevant studies were reviewed with a structured data abstraction form. MEASUREMENTS AND MAIN RESULTS A total of 235 articles were identified, and 51 met criteria for review: 24 practice guidelines, 22 studies of screening patterns, and 5 interventions designed to increase BMD rates. Of the practice guidelines, almost one half (47%) lacked a formal description of how they were developed, and recommendations for populations to screen varied widely. Screening frequencies among at-risk patients were low, ranging from 1% to 47%. Only eight studies assessed factors associated with BMD testing. Female patient gender, glucocorticoid dose, and rheumatologist care were positively associated with BMD testing; female physicians, rheumatologists, and physicians caring for more postmenopausal patients were more likely to test patients. Five articles described interventions to increase BMD testing rates, but only two tested for statistical significance and no firm conclusions can be drawn. CONCLUSIONS This systematic review identified several possible contributors to suboptimal BMD testing rates. Osteoporosis screening guidelines lack uniformity in their development and content. While some patient and physician characteristics were found to be associated with BMD testing, few articles carefully assessed correlates of testing. Almost no interventions to improve BMD testing to screen for osteoporosis have been rigorously evaluated.

[1]  C. Cooper,et al.  Guidelines for diagnosis and management of osteoporosis , 2005, Osteoporosis International.

[2]  D. Shewmon,et al.  Hip fracture patients are not treated for osteoporosis: a call to action. , 2002, Arthritis and rheumatism.

[3]  J. Katz,et al.  Management of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis: rates and predictors of care in an academic rheumatology practice. , 2002, Arthritis and rheumatism.

[4]  C. Ambrose,et al.  Undertreatment of osteoporosis in men with hip fracture. , 2002, Archives of internal medicine.

[5]  J. Peipert,et al.  Screening for Osteoporosis in Postmenopausal Women: Recommendations and Rationale , 2002, Annals of Internal Medicine.

[6]  P. Ebeling,et al.  Preventing osteoporosis: outcomes of the Australian Fracture Prevention Summit , 2002, The Medical journal of Australia.

[7]  R. Keen,et al.  Usefulness of bone densitometry in postmenopausal women with clinically diagnosed vertebral fractures , 2002, Annals of the rheumatic diseases.

[8]  O. Geling,et al.  Missed opportunities for prevention of osteoporotic fracture. , 2002, Archives of internal medicine.

[9]  Pamela A. Shaw,et al.  Prostate-specific antigen testing in black and white men: an analysis of medicare claims from 1991-1998. , 2002, Urology.

[10]  J. Compston,et al.  Guidelines on the management of osteoporosis associated with chronic liver disease , 2002, Gut.

[11]  M. Carnes,et al.  Outcomes and Secondary Prevention Strategies for Male Hip Fractures , 2002, The Annals of pharmacotherapy.

[12]  B. Gudbjornsson,et al.  Prevalence of long term steroid treatment and the frequency of decision making to prevent steroid induced osteoporosis in daily clinical practice , 2002, Annals of the rheumatic diseases.

[13]  J. Nolla,et al.  Usefulness of bone densitometry in postmenopausal women with clinically diagnosed vertebral fractures , 2002, Annals of the rheumatic diseases.

[14]  M. Pazirandeh Does patient partnership in continuing medical education (CME) improve the outcome in osteoporosis management? , 2002, The Journal of continuing education in the health professions.

[15]  Jacques P. Brown,et al.  2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. , 2002, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[16]  P. Hoffmeyer,et al.  An Osteoporosis Clinical Pathway for the Medical Management of Patients with Low-Trauma Fracture , 2002, Osteoporosis International.

[17]  M. Ahern,et al.  Missing a therapeutic window of opportunity: an audit of patients attending a tertiary teaching hospital with potentially osteoporotic hip and wrist fractures. , 2001, The Journal of rheumatology.

[18]  H. Rodbard,et al.  American Association of Clinical Endocrinologists 2001 Medical Guidelines for Clinical Practice for the Prevention and Management of Postmenopausal Osteoporosis. , 2001, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[19]  B. Ettinger,et al.  Prevalence and determinants of osteoporosis drug prescription among patients with high exposure to glucocorticoid drugs. , 2001, The American journal of managed care.

[20]  J. Allison,et al.  Variations in glucocorticoid induced osteoporosis prevention in a managed care cohort. , 2001, The Journal of rheumatology.

[21]  M. Ahern,et al.  Prevention of corticosteroid induced osteoporosis in inpatients recently discharged from a tertiary teaching hospital. , 2001, The Journal of rheumatology.

[22]  M. Hochberg,et al.  Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 Update: American College of Rheumatology Ad Hoc Committee on glucocorticoid-induced osteoporosis , 2001 .

[23]  D. Hosking,et al.  An audit of current clinical practice in the management of osteoporosis in Nottingham. , 2000, Journal of public health medicine.

[24]  J. Compston,et al.  Prevention and Treatment of Osteoporosis: Clinical Guidelines and New Evidence , 2000, Journal of the Royal College of Physicians of London.

[25]  E. Seely,et al.  Provider characteristics: impact on bone density utilization at a health maintenance organization , 2000, Menopause.

[26]  G. Hawker,et al.  Patterns of use of the bone mineral density test in Ontario, 1992-1998. , 2000, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[27]  E. E. Hajcsar,et al.  Investigation and treatment of osteoporosis in patients with fragility fractures. , 2000, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[28]  R. Sloane,et al.  Expert Physician Recommendations and Current Practice Patterns for Evaluating and Treating Men with Osteoporotic Hip Fracture , 2000, Journal of the American Geriatrics Society.

[29]  H. Perry,et al.  Failure to diagnose and treat osteoporosis in elderly patients hospitalized with hip fracture. , 2000, The American journal of medicine.

[30]  W. Bilker,et al.  Treatment of Osteoporosis: Are Physicians Missing an Opportunity?*† , 2000, The Journal of bone and joint surgery. American volume.

[31]  L. Moreland,et al.  Practice Pattern Variation Among Internal Medicine Specialists in the Prevention of Glucocorticoid‐Induced Osteoporosis , 2000, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[32]  P. Salkovskis,et al.  The effect of nondirective questioning on women's decisions whether to undergo bone density screening: an experimental study. , 2000, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[33]  M. Ruffin,et al.  Predictors of Screening for Breast, Cervical, Colorectal, and Prostatic Cancer Among Community-Based Primary Care Practices , 2000, The Journal of the American Board of Family Medicine.

[34]  G. Wood,et al.  Osteoporosis Disease Management: Best Practices from the Penn State Geisinger Health System , 2000 .

[35]  G. Hawker,et al.  Use of Bone Densitometry by Ontario Family Physicians , 2000, Osteoporosis International.

[36]  State-specific cholesterol screening trends--United States, 1991-1999. , 2000, MMWR. Morbidity and mortality weekly report.

[37]  R. Feezor,et al.  Prevention of corticosteroid-induced osteoporosis: results of a patient survey. , 1999, Arthritis and rheumatism.

[38]  R. Rizzoli,et al.  Diagnosis and management of osteoporosis in postmenopausal women: clinical guidelines. International Committee for Osteoporosis Clinical Guidelines. , 1999, Clinical therapeutics.

[39]  J. Stevenson Management of corticosteroid-induced osteoporosis , 1998, The Lancet.

[40]  C. Cooper,et al.  A UK Consensus Group on management of glucocorticoid‐induced osteoporosis: an update , 1998, Journal of internal medicine.

[41]  M. Morris,et al.  Clinical Reporting to Primary Care Physicians Leads to Increased Use and Understanding of Bone Densitometry and Affects the Management of Osteoporosis , 1998, Annals of Internal Medicine.

[42]  C. Cooper,et al.  Management of male osteoporosis: report of the UK Consensus Group. , 1998, QJM : monthly journal of the Association of Physicians.

[43]  National Osteoporosis Foundation Osteoporosis: Review of the Evidence for Prevention, Diagnosis and Treatment and Cost-Effective Analysis , 1998, Osteoporosis International.

[44]  M. Evans,et al.  Clinical practice guidelines for the diagnosis and management of osteoporosis , 1997 .

[45]  S. Hodgson AACE Clinical Practice Guidelines for the Prevention and Treatment of Postmenopausal Osteoporosis. , 2011, The Journal of the Florida Medical Association.

[46]  D. Hanley,et al.  Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 2. The use of bone density measurement in the diagnosis and management of osteoporosis. , 1996, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[47]  O Johnell,et al.  Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. , 1996, BMJ.

[48]  S. Cummings,et al.  Bone density at various sites for prediction of hip fractures , 1993, The Lancet.

[49]  S Kamen,et al.  The task force. , 1976, Journal of hospital dental practice.